The functional diffusion map: an imaging biomarker for the early prediction of cancer treatment outcome.
暂无分享,去创建一个
Bradford A Moffat | Timothy D Johnson | Alnawaz Rehemtulla | Thomas L Chenevert | Brian D Ross | Daniel E Hall | Daniel E. Hall | C. Meyer | T. Chenevert | B. Ross | T. Johnson | A. Rehemtulla | D. E. Hall | B. Moffat | P. Mckeever | B. Hoff | Charles R Meyer | Benjamin A Hoff | Paul E McKeever
[1] J. B. Moody,et al. Diffusion imaging for evaluation of tumor therapies in preclinical animal models , 2004, Magnetic Resonance Materials in Physics, Biology and Medicine.
[2] C. Meyer,et al. Sodium and proton diffusion MRI as biomarkers for early therapeutic response in subcutaneous tumors. , 2006, Magnetic resonance imaging.
[3] Thomas L Chenevert,et al. Magnetic Resonance Imaging and Spectroscopy: Application to Experimental Neuro-Oncology. , 1994, Quarterly of magnetic resonance in biology and medicine.
[4] Thomas L. Chenevert,et al. Molecular Imaging of Gene Expression and Efficacy following Adenoviral-Mediated Brain Tumor Gene Therapy , 2002 .
[5] T. Chenevert,et al. Contributions of cell kill and posttreatment tumor growth rates to the repopulation of intracerebral 9L tumors after chemotherapy: an MRI study. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[6] Toshinori Hirai,et al. Usefulness of diffusion‐weighted MRI with echo‐planar technique in the evaluation of cellularity in gliomas , 1999, Journal of magnetic resonance imaging : JMRI.
[7] C. Meyer,et al. Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[8] J. Griffiths,et al. The C-neu mammary carcinoma in Oncomice; characterization and monitoring response to treatment with herceptin by magnetic resonance methods , 2004, Magnetic Resonance Materials in Physics, Biology and Medicine.
[9] T. Chenevert,et al. Magnetic resonance imaging in cancer research. , 2002, European journal of cancer.
[10] S. Maier,et al. High-b-value diffusion-weighted MR imaging for pretreatment prediction and early monitoring of tumor response to therapy in mice. , 2004, Radiology.
[11] P. Grenier,et al. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. , 1986, Radiology.
[12] Olav Haraldseth,et al. Measurement of cell density and necrotic fraction in human melanoma xenografts by diffusion weighted magnetic resonance imaging , 2000, Magnetic resonance in medicine.
[13] Jean-Philippe Galons,et al. Early response of prostate carcinoma xenografts to docetaxel chemotherapy monitored with diffusion MRI. , 2002, Neoplasia.
[14] Charles R. Meyer,et al. Demonstration of accuracy and clinical versatility of mutual information for automatic multimodality image fusion using affine and thin-plate spline warped geometric deformations , 1997, Medical Image Anal..
[15] J. Pipe,et al. Early detection of treatment response by diffusion-weighted 1H-NMR spectroscopy in a murine tumour in vivo. , 1996, British Journal of Cancer.
[16] Bradford A Moffat,et al. Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[17] Daniel E. Hall,et al. Molecular imaging of gene expression and efficacy following adenoviral-mediated brain tumor gene therapy. , 2002, Molecular imaging.
[18] Bradford A Moffat,et al. Dynamic imaging of emerging resistance during cancer therapy. , 2006, Cancer research.
[19] Bradford A Moffat,et al. Evaluation of cancer therapy using diffusion magnetic resonance imaging. , 2003, Molecular cancer therapeutics.
[20] Bradford A Moffat,et al. The use of 19F spectroscopy and diffusion-weighted MRI to evaluate differences in gene-dependent enzyme prodrug therapies. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.
[21] R. Gillies,et al. Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy. , 2004, Neoplasia.
[22] Robert J Gillies,et al. Dynamic contrast-enhanced and diffusion MRI show rapid and dramatic changes in tumor microenvironment in response to inhibition of HIF-1alpha using PX-478. , 2005, Neoplasia.
[23] R. Gillies,et al. Applications of magnetic resonance in model systems: cancer therapeutics. , 2000, Neoplasia.
[24] Bradford A. Moffat,et al. Diffusion MRI: A New Strategy for Assessment of Cancer Therapeutic Efficacy , 2002, Molecular imaging.
[25] J. M. Taylor,et al. Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. , 2000, Journal of the National Cancer Institute.
[26] Stephan E Maier,et al. Early detection of response to radiation therapy in patients with brain malignancies using conventional and high b-value diffusion-weighted magnetic resonance imaging. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] T L Chenevert,et al. Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[28] Alexander de Vries,et al. Preliminary Results on the Influence of Chemoradiation on Apparent Diffusion Coefficients of Primary Rectal Carcinoma Measured by Magnetic Resonance Imaging , 2003, Strahlentherapie und Onkologie.
[29] R. Gillies,et al. Early increases in breast tumor xenograft water mobility in response to paclitaxel therapy detected by non-invasive diffusion magnetic resonance imaging. , 1999, Neoplasia.
[30] Bradford A Moffat,et al. Therapeutic Efficacy of DTI-015 using Diffusion Magnetic Resonance Imaging as an Early Surrogate Marker , 2004, Clinical Cancer Research.
[31] Alnawaz Rehemtulla,et al. Sodium magnetic resonance imaging of chemotherapeutic response in a rat glioma , 2005, Magnetic resonance in medicine.
[32] Stephan E Maier,et al. Pretreatment prediction of brain tumors' response to radiation therapy using high b-value diffusion-weighted MRI. , 2004, Neoplasia.
[33] A. Rehemtulla,et al. Fusion of the HSV-1 tegument protein vp22 to cytosine deaminase confers enhanced bystander effect and increased therapeutic benefit , 2006, Gene Therapy.
[34] A. Rehemtulla,et al. Diffusion MRI detects early events in the response of a glioma model to the yeast cytosine deaminase gene therapy strategy , 2000, Gene Therapy.
[35] Jürgen Griebel,et al. Diffusion-weighted magnetic resonance imaging for monitoring diffusion changes in rectal carcinoma during combined, preoperative chemoradiation: preliminary results of a prospective study. , 2003, European journal of radiology.
[36] T L Chenevert,et al. Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.